SCA
Summit Creek Advisors’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Hold |
1,032
| – | – | 0.03% | 68 |
|
|
2025
Q1 | $231K | Buy |
1,032
+5
| +0.5% | +$1.12K | 0.03% | 66 |
|
|
2024
Q4 | $336K | Hold |
1,027
| – | – | 0.04% | 62 |
|
|
2024
Q3 | $308K | Sell |
1,027
-66
| -6% | -$19.8K | 0.04% | 67 |
|
|
2024
Q2 | $360K | Hold |
1,093
| – | – | 0.05% | 60 |
|
|
2024
Q1 | $433K | Buy |
1,093
+14
| +1% | +$5.54K | 0.05% | 59 |
|
|
2023
Q4 | $380K | Hold |
1,079
| – | – | 0.05% | 58 |
|
|
2023
Q3 | $405K | Hold |
1,079
| – | – | 0.06% | 58 |
|
|
2023
Q2 | $413K | Buy |
1,079
+1
| +0.1% | +$382 | 0.05% | 60 |
|
|
2023
Q1 | $373K | Hold |
1,078
| – | – | 0.05% | 61 |
|
|
2022
Q4 | $254K | Buy |
1,078
+9
| +0.8% | +$2.12K | 0.03% | 68 |
|
|
2022
Q3 | $263K | Sell |
1,069
-767
| -42% | -$189K | 0.04% | 66 |
|
|
2022
Q2 | $555K | Buy |
1,836
+28
| +2% | +$8.46K | 0.07% | 64 |
|
|
2022
Q1 | $743K | Buy |
1,808
+10
| +0.6% | +$4.11K | 0.08% | 64 |
|
|
2021
Q4 | $843K | Buy |
1,798
+4
| +0.2% | +$1.88K | 0.08% | 64 |
|
|
2021
Q3 | $762K | Buy |
1,794
+450
| +33% | +$191K | 0.08% | 65 |
|
|
2021
Q2 | $483K | Hold |
1,344
| – | – | 0.06% | 62 |
|
|
2021
Q1 | $379K | Buy |
1,344
+374
| +39% | +$105K | 0.05% | 63 |
|
|
2020
Q4 | $275K | Sell |
970
-2,940
| -75% | -$834K | 0.04% | 64 |
|
|
2020
Q3 | $1.08M | Hold |
3,910
| – | – | 0.16% | 61 |
|
|
2020
Q2 | $888K | Hold |
3,910
| – | – | 0.13% | 62 |
|
|
2020
Q1 | $595K | Hold |
3,910
| – | – | 0.12% | 63 |
|
|
2019
Q4 | $588K | Hold |
3,910
| – | – | 0.09% | 62 |
|
|
2019
Q3 | $555K | Buy |
+3,910
| New | +$555K | 0.09% | 62 |
|